202 related articles for article (PubMed ID: 34571713)
1. GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment.
Bouchard A; Collin B; Garrido C; Bellaye PS; Kohli E
Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571713
[TBL] [Abstract][Full Text] [Related]
2. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.
Metelli A; Wu BX; Riesenberg B; Guglietta S; Huck JD; Mills C; Li A; Rachidi S; Krieg C; Rubinstein MP; Gewirth DT; Sun S; Lilly MB; Wahlquist AH; Carbone DP; Yang Y; Liu B; Li Z
Sci Transl Med; 2020 Jan; 12(525):. PubMed ID: 31915300
[TBL] [Abstract][Full Text] [Related]
3. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity.
Zimmer N; Trzeciak ER; Graefen B; Satoh K; Tuettenberg A
Front Immunol; 2022; 13():928450. PubMed ID: 35898500
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer.
Metelli A; Salem M; Wallace CH; Wu BX; Li A; Li X; Li Z
J Hematol Oncol; 2018 Feb; 11(1):24. PubMed ID: 29458436
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.
Huygens C; Liénart S; Dedobbeleer O; Stockis J; Gauthy E; Coulie PG; Lucas S
J Biol Chem; 2015 Aug; 290(33):20105-16. PubMed ID: 26126825
[TBL] [Abstract][Full Text] [Related]
6. GARP on hepatic stellate cells is essential for the development of liver fibrosis.
Zhang X; Sharma P; Maschmeyer P; Hu Y; Lou M; Kim J; Fujii H; Unutmaz D; Schwabe RF; Winau F
J Hepatol; 2023 Nov; 79(5):1214-1225. PubMed ID: 37348791
[TBL] [Abstract][Full Text] [Related]
7. Garp as a therapeutic target for modulation of T regulatory cell function.
Shevach EM
Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF-β1/GARP Complex.
Li Y; Kim BG; Qian S; Letterio JJ; Fung JJ; Lu L; Lin F
J Immunol; 2015 Sep; 195(6):2648-56. PubMed ID: 26246140
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex.
Niu J; Yue W; Le-Le Z; Bin L; Hu X
Oncotarget; 2017 Nov; 8(59):99784-99800. PubMed ID: 29245940
[TBL] [Abstract][Full Text] [Related]
10. Spatial Distribution of Non-Immune Cells Expressing Glycoprotein A Repetitions Predominant in Human and Murine Metastatic Lymph Nodes.
Rouaud L; Baudin L; Gautier-Isola M; Van Meerbeeck P; Feyereisen E; Blacher S; van Baren N; Kridelka F; Lucas S; Noel A
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067325
[TBL] [Abstract][Full Text] [Related]
11. Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients.
Jin H; Sun L; Tang L; Yu W; Li H
Front Immunol; 2017; 8():138. PubMed ID: 28261204
[TBL] [Abstract][Full Text] [Related]
12. A key role of GARP in the immune suppressive tumor microenvironment.
Hahn SA; Neuhoff A; Landsberg J; Schupp J; Eberts D; Leukel P; Bros M; Weilbaecher M; Schuppan D; Grabbe S; Tueting T; Lennerz V; Sommer C; Jonuleit H; Tuettenberg A
Oncotarget; 2016 Jul; 7(28):42996-43009. PubMed ID: 27248166
[TBL] [Abstract][Full Text] [Related]
13. How Soluble GARP Enhances TGFβ Activation.
Fridrich S; Hahn SA; Linzmaier M; Felten M; Zwarg J; Lennerz V; Tuettenberg A; Stöcker W
PLoS One; 2016; 11(4):e0153290. PubMed ID: 27054568
[TBL] [Abstract][Full Text] [Related]
14. Platelet-Derived GARP Induces Peripheral Regulatory T Cells-Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis.
Zimmer N; Krebs FK; Zimmer S; Mitzel-Rink H; Kumm EJ; Jurk K; Grabbe S; Loquai C; Tuettenberg A
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291452
[TBL] [Abstract][Full Text] [Related]
15. New insight into GARP striking role in cancer progression: application for cancer therapy.
Lahimchi MR; Eslami M; Yousefi B
Med Oncol; 2022 Dec; 40(1):33. PubMed ID: 36460874
[TBL] [Abstract][Full Text] [Related]
16. GARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasing.
Sun L; Jin H; Li H
Oncotarget; 2016 Jul; 7(27):42826-42836. PubMed ID: 27095576
[TBL] [Abstract][Full Text] [Related]
17. Anti-GARP Antibodies Inhibit Release of TGF-β by Regulatory T Cells via Different Modes of Action, but Do Not Influence Their Function In Vitro.
Igney FH; Ebenhoch R; Schiele F; Nar H
Immunohorizons; 2023 Mar; 7(3):200-212. PubMed ID: 36928178
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
[TBL] [Abstract][Full Text] [Related]
19. GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme.
Zimmer N; Kim E; Sprang B; Leukel P; Khafaji F; Ringel F; Sommer C; Tuettenberg J; Tuettenberg A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357555
[TBL] [Abstract][Full Text] [Related]
20. Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer.
Metelli A; Wu BX; Fugle CW; Rachidi S; Sun S; Zhang Y; Wu J; Tomlinson S; Howe PH; Yang Y; Garrett-Mayer E; Liu B; Li Z
Cancer Res; 2016 Dec; 76(24):7106-7117. PubMed ID: 27913437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
